Gf Fund Management Co. Ltd. Biogen Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Biogen Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 35,435 shares of BIIB stock, worth $4.5 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
35,435
Previous 34,242
3.48%
Holding current value
$4.5 Million
Previous $5.24 Billion
7.4%
% of portfolio
0.11%
Previous 0.11%
Shares
2 transactions
Others Institutions Holding BIIB
# of Institutions
1,026Shares Held
127MCall Options Held
2.29MPut Options Held
4.26M-
Vanguard Group Inc Valley Forge, PA17MShares$2.16 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.9MShares$2.03 Billion1.84% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.85 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$940 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.67MShares$594 Million0.13% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $18.3B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...